IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


(Investigative Ophthalmology and Visual Science. 2004;45:1149-1156.)
© 2004 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.03-0404

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (18)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Panicker, S. G.
Right arrow Articles by Hasnain, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Panicker, S. G.
Right arrow Articles by Hasnain, S. E.

Correlations of Genotype with Phenotype in Indian Patients with Primary Congenital Glaucoma

Shirly G. Panicker,1 Anil K. Mandal,2 Aramati B. M. Reddy,1 Vijaya K. Gothwal,3 and Seyed E. Hasnain4

1From the Kallam Anji Reddy Molecular Genetics Laboratory, Brien Holden Eye Research Centre, Hyderabad Eye Research Foundation, Hyderabad, India; the 2Jasti V. Ramanamma Children’s Eye Care Centre, Hyderabad, India; the 3Centre for Sight Enhancement, Vision Rehabilitation Centres, L.V. Prasad Eye Institute, Hyderabad, India; and the 4Centre for DNA Fingerprinting and Diagnostics, Hyderabad, India.

PURPOSE. To establish the genotype–phenotype correlations of various CYP1B1 (human cytochrome P450) mutations in patients in India with primary congenital glaucoma (PCG).

METHODS. The study cohort comprised 146 patients with PCG from 138 pedigrees. Patients were analyzed for six distinct CYP1B1 mutations by sequencing and polymerase chain reaction–restriction fragment length polymorphism (PCR-RFLP) methods. A severity index for grading various PCG phenotypes was constructed based on clinical parameters.

RESULTS. Six mutations were identified in 45 patients analyzed and genotype–phenotype correlations were established for 43 of them. The percentages of severe phenotypes associated with various mutations in at least one eye were: frameshift, 100%; G61E, 66.7%; P193L, 62.5%; E229K, 80%; R368H, 72%; R390C, 83.3%. The frameshift mutation resulted in blindness. Based on the severity index, the disease severity was graded from normal to severe and the prognosis from good to very poor (blind). De novo mutation was identified in one family.

CONCLUSIONS. This is the first study to attempt to devise a severity index for grading various PCG phenotypes and to use genotype as an indicator to predict the prognoses of the disorder. This index may help guide therapy and counseling of the afflicted family regarding the progression of the disorder. All patients with severe phenotypes showed poor prognoses (r = 0.976; P < 0.0001). The data derived from this study could be used as an added clinical tool in disease management. Integrated management of PCG that makes use of a genetic approach could yield better results than medical, surgical, and rehabilitation interventions alone.





This article has been cited by other articles:


Home page
J. Mol. Diagn.Home page
F. Chitsazian, B. K. Tusi, E. Elahi, H. A. Saroei, M. H. Sanati, S. Yazdani, M. Pakravan, N. Nilforooshan, Y. Eslami, M. A. Z. Mehrjerdi, et al.
CYP1B1 Mutation Profile of Iranian Primary Congenital Glaucoma Patients and Associated Haplotypes
J. Mol. Diagn., July 1, 2007; 9(3): 382 - 393.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
M. S. Achary, A. B. M. Reddy, S. Chakrabarti, S. G. Panicker, A. K. Mandal, N. Ahmed, D. Balasubramanian, S. E. Hasnain, and H. A. Nagarajaram
Disease-Causing Mutations in Proteins: Structural Analysis of the CYP1b1 Mutations Causing Primary Congenital Glaucoma in Humans
Biophys. J., December 15, 2006; 91(12): 4329 - 4339.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
C. Bidinost, N. Hernandez, D. P. Edward, A. Al-Rajhi, R. A. Lewis, J. R. Lupski, D. W. Stockton, and B. A. Bejjani
Of mice and men: tyrosinase modification of congenital glaucoma in mice but not in humans.
Invest. Ophthalmol. Vis. Sci., April 1, 2006; 47(4): 1486 - 1490.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. Chakrabarti, K. Kaur, I. Kaur, A. K. Mandal, R. S. Parikh, R. Thomas, and P. P. Majumder
Globally, CYP1B1 Mutations in Primary Congenital Glaucoma Are Strongly Structured by Geographic and Haplotype Backgrounds
Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 43 - 47.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the Association for Research in Vision and Ophthalmology